A

ARTHEx Biotech

15 employees

AntagomiR oligonucleotides to treat Myotonic Dystrophy patients.

Basic info

Industry

biotechnology research

Sectors

farma
Biotechnology
Enfermedades raras
Oligonucleotidos terapéuticos
health
biotecnología
Desarrollo de fármacos
biotech

Date founded

2019

Funding rounds raised

Total raised

$5M

from 2 investors over 2 rounds

A

ARTHEx Biotech raised $5M on July 24, 2020

Investors: AdBio partners

A

ARTHEx Biotech raised $1.3M on June 1, 2020

Investors: CDTI, Centre for the Development of Industrial Technology

FAQ